Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) Short Interest Down 66.7% in January

Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) saw a large drop in short interest in the month of January. As of January 15th, there was short interest totalling 200 shares, a drop of 66.7% from the December 31st total of 600 shares. Based on an average trading volume of 800 shares, the days-to-cover ratio is currently 0.3 days.

Mosaic ImmunoEngineering Stock Performance

Shares of Mosaic ImmunoEngineering stock remained flat at $0.98 during midday trading on Tuesday. The company had a trading volume of 25 shares, compared to its average volume of 564. The firm has a 50 day simple moving average of $0.88 and a 200 day simple moving average of $0.88. Mosaic ImmunoEngineering has a 1-year low of $0.10 and a 1-year high of $1.13. The company has a market capitalization of $7.10 million, a price-to-earnings ratio of -6.53 and a beta of 0.27.

About Mosaic ImmunoEngineering

Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.